They should not be read as statements about broad availability, suitability for an individual, or permission to use these substances for any particular purpose
Xing Y et al., Front Endocrinol, 2021
Ralph DeFronzo, a diabetes expert and researcher at the University of Texas Health Science Center in San Antonio, advised that these two medication classes be considered first when treating type 2 diabetes because they help preserve beta-cell function
Third, we characterized the primary receptor for CXCL10 in the ovaries, IL18R1, and showed that it dominates over CXCR3 in binding to CXCL10
Nature Communications , 8 , 16013